W-Z. Zhong - Sch Med, South China Univ Technol

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 27 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Ventana ALK (D5F3) Immunohistochemistry Improves the Accuracy of Pathologic Assessment after Neoadjuvant ALK-TKIs for ALK-Positive NSCLC

L. -X. Yan, Q. Cui, Q. Zhou,X. -N. Yang,W. -Z. Zhong,Z. -Y. Liu,Q. -L. Zhang,Y. -L. Wu

JOURNAL OF THORACIC ONCOLOGYno. 11 (2023): S245-S245

引用0浏览0引用

P1.23-09 Cerebrospinal Fluid Ctdna Based Therapy Associated with Survival of CNS Metastases in Advanced NSCLC: A Large Scale, Comprehensive Study

M.-M. Zheng, L.-B. Tang,H.-Y. Tu,B.-Y. Jiang,K. Yin,J.-J. Yang, X.-C. Zhang,Y. Pan,B.-C. Wang, H.-J. Chen, H. Sun, Z. Wang,C.-R. Xu,W.-Z. Zhong, T. Hou, D.-Q. Zhu,Q. Zhou,Y.-S. Li,Y.-L. Wu

Journal of Thoracic Oncologyno. 11 (2023): S258-S259

引用0浏览0引用

Neoadjuvant PD-1 Blockade Plus Platinum-based Chemotherapy for EGFR-mutant NSCLC (CTONG2104): An Interim Analysis

C. Zhang,D. -C. Yi, Y. -X. Sun,B. -Y. Jiang,L. -X. Yan,L. -S. Peng,S. -Y. Liu, J. Yang, H. Sun,D. Peng, Y. -S. Li,S. -A. Chen,R. -Q. Liao,X. -N. Yang,Q. Zhou,Y. -L. Wu,Z. -M. Zhang,W. -Z. Zhong

JOURNAL OF THORACIC ONCOLOGYno. 11 (2023): S284-S284

引用0浏览0引用

P2.03-05 Clinical Impact of Genomic Characterization in Induced Oligometastatic Non-small Cell Lung Cancer

R. Fu, Y. -Y. Xiong, F. Li,M. Cai,R. -R. Chen, H. -J. Li, Y. -L. Wu,W. -Z. Zhong

JOURNAL OF THORACIC ONCOLOGYno. 11 (2023): S303-S304

引用0浏览0引用

EP08.01-02 Single-Cell RNA Sequencing Reveals Unique Immune Landscape in Rare-Mutant Non-Small Cell Lung Cancer Undergoing Chemo-Immunotherapy

R. Fu, C. Zhang, M. -M. Song, X. Gao,X. -F. Xia,M. Cai, F. Li, Y. -L. Wu,W. -Z. Zhong

JOURNAL OF THORACIC ONCOLOGYno. 11 (2023): S566-S567

引用0浏览0引用

P1.22-03 Ventana ALK (D5F3) Immunohistochemistry Improves the Accuracy of Pathologic Assessment after Neoadjuvant ALK-TKIs for ALK-Positive NSCLC

L.-X. Yan, Q. Cui, Q. Zhou,X.-N. Yang,W.-Z. Zhong,Z.-Y. Liu,Q.-L. Zhang,Y.-L. Wu

Journal of Thoracic Oncologyno. 11 (2023): S245

引用0浏览0引用

EP08.01-01 Subtyping EGFR-mutated NSCLC Patients with Adjuvant TKIs or Chemotherapy Using Deep Radiomic Signatures

Y. -F. Qi, J. Li,Z. -B. Qiu,Y. -L. Wu,X. Zhang,W. -Z. Zhong

JOURNAL OF THORACIC ONCOLOGYno. 11 (2023): S565-S566

引用0浏览0引用

P1.27-03 Neoadjuvant PD-1 Blockade Plus Platinum-based Chemotherapy for EGFR-mutant NSCLC (CTONG2104): An Interim Analysis

C. Zhang,D.-C. Yi, Y.-X. Sun,B.-Y. Jiang,L.-X. Yan,L.-S. Peng,S.-Y. Liu,J. Yang, H. Sun,D. Peng, Y.-S. Li,S.-A. Chen,R.-Q. Liao,X.-N. Yang,Q. Zhou,Y.-L. Wu,Z.-M. Zhang,W.-Z. Zhong

Journal of Thoracic Oncologyno. 11 (2023): S284-S284

引用0浏览0引用

P1.03-01 Dynamic Transcriptomic Characterization Changes of Early Stage Lung Adenocarcinoma As Per the Incrassation of Consolidation Tumor Ratio

Z-B. Qiu, J. Li, H. -J. Li,M. -M. Wang,Y. -L. Wu,X. Zhang,W. -Z. Zhong

Journal of thoracic oncologyno. 11 (2023): S191-S191

引用0浏览0引用

WS02.18 Cerebrospinal Fluid Ctdna Based Therapy Associated with Survival of CNS Metastases in Advanced NSCLC: A Large Scale, Comprehensive Study

M.-M. Zheng, L.-B. Tang,H.-Y. Tu,B.-Y. Jiang,K. Yin,J.-J. Yang, X.-C. Zhang,Y. Pan,B.-C. Wang, H.-J. Chen, H. Sun, Z. Wang,C.-R. Xu,W.-Z. Zhong, T. Hou, D.-Q. Zhu,Q. Zhou, Y.-S. Li,Y.-L. Wu

Journal of Thoracic Oncologyno. 11 (2023): S40-S41

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn